(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.03%) $0.927
(-0.03%) $10.84
(-0.13%) $0.791
(-0.24%) $92.35
Live Chart Being Loaded With Signals
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally...
Stats | |
---|---|
Today's Volume | 29 162.00 |
Average Volume | 13 337.00 |
Market Cap | 815.77M |
EPS | $0 ( 2024-02-26 ) |
Next earnings date | ( $0 ) 2024-05-06 |
Last Dividend | $2.20 ( 2023-11-30 ) |
Next Dividend | $0 ( N/A ) |
P/E | 42.10 |
ATR14 | $1.746 (0.38%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-08 | Ferguson Cindy | Sell | 163 | restricted stock units |
2024-03-08 | Ferguson Cindy | Buy | 163 | common stock |
2024-03-08 | Ferguson Cindy | Sell | 45 | common stock |
2024-01-02 | Stupp John P Jr | Buy | 10 | stock units |
2024-01-02 | Ferguson Cindy | Buy | 14 | restricted stock units |
INSIDER POWER |
---|
-9.12 |
Last 93 transactions |
Buy: 23 820 | Sell: 40 633 |
Atrion Corp Correlation
10 Most Positive Correlations | |
---|---|
NTGR | 0.882 |
WMG | 0.879 |
BOWX | 0.877 |
TUEM | 0.871 |
DMTK | 0.867 |
ZD | 0.864 |
SBAC | 0.861 |
GDS | 0.861 |
MRNA | 0.856 |
COLM | 0.856 |
10 Most Negative Correlations | |
---|---|
FRHC | -0.869 |
MTRY | -0.861 |
KSICU | -0.859 |
AVDL | -0.859 |
MORF | -0.859 |
COKE | -0.859 |
DKNG | -0.854 |
OTTR | -0.844 |
NBSTU | -0.842 |
PTOC | -0.839 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Atrion Corp Financials
Annual | 2023 |
Revenue: | $169.33M |
Gross Profit: | $62.39M (36.84 %) |
EPS: | $11.02 |
Q4 | 2023 |
Revenue: | $43.58M |
Gross Profit: | $16.32M (37.44 %) |
EPS: | $3.65 |
Q3 | 2023 |
Revenue: | $41.91M |
Gross Profit: | $13.74M (32.77 %) |
EPS: | $1.670 |
Q2 | 2023 |
Revenue: | $43.84M |
Gross Profit: | $17.25M (39.36 %) |
EPS: | $3.73 |
Financial Reports:
No articles found.
Atrion Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$2.15 (N/A) |
$2.15 (N/A) |
$2.15 (N/A) |
$2.15 (N/A) |
$2.20 (N/A) |
$2.20 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.183 | 1990-02-12 |
Last Dividend | $2.20 | 2023-11-30 |
Next Dividend | $0 | N/A |
Payout Date | 2023-12-15 | |
Next Payout Date | N/A | |
# dividends | 117 | -- |
Total Paid Out | $94.61 | -- |
Avg. Dividend % Per Year | 0.85% | -- |
Score | 4.19 | -- |
Div. Sustainability Score | 6.28 | |
Div.Growth Potential Score | 2.73 | |
Div. Directional Score | 4.51 | -- |
Year | Amount | Yield |
---|---|---|
1990 | $0.732 | 9.87% |
1991 | $0.732 | 7.71% |
1992 | $0.783 | 7.12% |
1993 | $0.800 | 5.27% |
1994 | $0.800 | 5.78% |
1995 | $0.800 | 7.27% |
1996 | $0.800 | 5.60% |
1997 | $0.600 | 3.87% |
1998 | $0 | 0.00% |
1999 | $0 | 0.00% |
2000 | $0 | 0.00% |
2001 | $0 | 0.00% |
2002 | $0 | 0.00% |
2003 | $0.240 | 1.07% |
2004 | $0.520 | 1.14% |
2005 | $0.620 | 1.33% |
2006 | $0.740 | 1.09% |
2007 | $0.880 | 1.12% |
2008 | $1.080 | 0.87% |
2009 | $1.320 | 1.36% |
2010 | $10.56 | 6.78% |
2011 | $1.820 | 0.97% |
2012 | $12.10 | 5.03% |
2013 | $2.40 | 1.19% |
2014 | $2.78 | 0.96% |
2015 | $3.30 | 0.97% |
2016 | $3.90 | 1.04% |
2017 | $4.50 | 0.90% |
2018 | $5.10 | 0.82% |
2019 | $5.80 | 0.79% |
2020 | $6.60 | 0.89% |
2021 | $7.40 | 1.13% |
2022 | $8.20 | 1.17% |
2023 | $8.70 | 1.53% |
2024 | $0 | 0.00% |
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.115 | 1.500 | 7.71 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0744 | 1.200 | 7.52 | 9.02 | [0 - 0.3] |
returnOnEquityTTM | 0.0807 | 1.500 | -0.215 | -0.322 | [0.1 - 1] |
payoutRatioTTM | 0.789 | -1.000 | 2.11 | -2.11 | [0 - 1] |
currentRatioTTM | 9.09 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 2.32 | 0.800 | 1.057 | 0.845 | [0.8 - 2.5] |
cashRatioTTM | 0.282 | 1.500 | 9.54 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | -9.13 | 1.000 | -4.49 | -4.49 | [3 - 30] |
operatingCashFlowPerShareTTM | 11.37 | 2.00 | 6.21 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | -1.314 | 2.00 | -0.657 | -1.314 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.368 | 1.000 | 7.19 | 7.19 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.117 | 1.000 | 9.66 | 9.66 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0.649 | 0.800 | 9.01 | 7.20 | [0.5 - 2] |
Total Score | 6.28 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 42.03 | 1.000 | 5.86 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0807 | 2.50 | -0.138 | -0.322 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -1.314 | 2.00 | -0.438 | -1.314 | [0 - 30] |
dividendYielPercentageTTM | 1.888 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 11.37 | 2.00 | 6.21 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.789 | 1.500 | 2.11 | -2.11 | [0 - 1] |
pegRatioTTM | -11.97 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.118 | 1.000 | 9.55 | 0 | [0.1 - 0.5] |
Total Score | 2.73 |
Atrion Corp
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators